)
featured
Stay up to date with Altos
Category:
AllLayout:
/
Press Releases
/
Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming
Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming.
Read more)
Updates
Peter Walter receives Frontiers of Knowledge Award in Biology and Biomedicine
Peter Walter, a Distinguished Investigator in our Bay Area Institute, received the BBVA Foundation’s Frontiers of Knowledge Award in Biology and Biomedicine.
Read more)
News
/
The Inverse reports on 'the cellular reset' and Altos' approach to reversing disease
Just like the tried-and-true fix for all electronic appliances that go haywire only to come back to full working order after a quick reboot, a reset switch within the body’s basic structure — a cell — might have a similarly restorative and rejuvenating effect.
Read more)
News
/
The Economist on Altos’ mission to “crack cellular rejuvenation”
The founders of Altos...seem deadly serious about what they are up to. Looking at discoveries in biology made over the past few decades...they believe they have glimpsed the outline of an answer to the question of how to reverse the process of cellular ageing. They have also recruited a star-studded scientific cast to help them track that answer down.
Read moreNews
/
Rick Klausner discusses the genesis of Altos with Endpoints News
The big idea here is that a network of Nobel Prize winners and other scientific luminaries allied with some top industry insiders and committed deep-pocket investors can go deep into the biology of cellular rejuvenation — a dream for Klausner, who has one of the best networks of cell researchers and investors in the business — to find durable therapies for a myriad of diseases while reversing the damage of disease, injury and disabilities.
Read moreNews
/
The Times on Altos’ mission and culture
Rather than making people live far longer, [Altos’ Cambridge Institute of Science Director Wolf Reik] says that the aim is to increase what’s known as “healthspan” — the number of years that humans spend free of disease.
Read more